How to Build a Successful Decentralized Clinical Trial and Avoid Common Mistakes

Decentralized trials have proven to allow continued recruitment and retention of patients, keeping trials and patient’s wellbeing on track, even during a pandemic.

For the past 15 years, MRN has been driving the successful implementation of decentralized clinical trials for the pharmacautical industry. MRN has spent over a decade advocating for a decentralized, patient-friendly approach to clinical trials, bringing trial visits to the patient in their own home and community. MRN successfully delivered a historical record number of visits in response to our most challenging chapter, helping our clients successfully navigate the Covid-19 pandemic. While the industry in recent years has discussed various decentralized, patient-centric strategies, Covid-19 brought their implementation to the very forefront of clinical trial development. As an industry, we saw sites close, studies lose their trial patients and hundreds of millions of research dollars at risk.

In response, both existing and new clients turned to MRN to help rescue their trials from imminent failure. New, rapid response teams and processes were created and implemented across the business to continue to support our clients. Our service offerings expanded, and we continued to strengthen our alliances with suppliers.

Register for this webinar to hear experts from MRN share their best practices in planning, implementation and integrations – things you need to know to successfully run a decentralized clinical trial. You will get a view into the successes, challenges and lessons learned from both sides of the table. They will introduce participants to their learnings and experience running trials during a pandemic and share their insights to designing trials that can incorporate decentralized services.

Speakers

Todd McGrath, Vice President, Global Head Project Management, MRN

Todd has over 16 years’ experience in the clinical trial and life science industry, beginning his career in pharmaceutical and biotech consulting and then holding operational positions at PAREXEL managing teams and projects.

As Vice President of Global Head Project Management, Todd oversees MRN’s global operations teams, developing and implementing project management strategies, continuous improvement and standardization across all regions. Todd’s leadership has been instrumental in guiding MRN’s pharma clients through the operational challenges that Covid-19 brought to their trial designs, sites and patients.

Message Presenter

Alison Occhiuti, Associate Director, Clinical Operations, Magenta Therapeutics

Alison, an accomplished clinical operations professional with over a decade of experience, is currently Associate Director of Clinical Operations at Magenta Therapeutics. She is responsible for the operational strategy and delivery of one of Magenta’s early clinical programs.

Prior joining Magenta, Alison managed clinical trials at Contract Research Organizations across a variety of indications before transitioning to the biopharmaceutical side in 2017. Since 2017, Alison has gained experience managing clinical trials for large pharma and small biotech companies with a distinct focus on rare diseases. In support of these rare disease trials and to mitigate the impact of Covid-19, Alison implemented decentralized clinical trial management/ homecare services both prospectively and mid-study.

Message Presenter